Basics Inhibrx, Inc. IPO Date: August 19, 2020 Sector: Healthcare Industry: Biotech Market Cap: $187.61M Activated in VL: True Average Daily Range Avg Daily Range: $0.79 | 3.45% Avg Daily Range (30 D): $0.44 | 3.58% Avg Daily Range (90 D): $0.36 | 2.87% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .08M Avg Daily Volume (90 D): .08M Trade Size Avg Trade Size (Sh.): 64 Avg Trade Size (Sh.) (30 D): 62 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 1,237 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $.58M Avg Inst. Trade (90 D): $.59M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.17M Avg Closing Trade (30 D): $.56M Avg Closing Trade (90 D): $.56M Avg Closing Volume: 82.15K     News Jul 23, 2024 @ 9:01 AM Inhibrx stock rated 'Market Perform' by JMP after ... Source: Emilio Ghigini Feb 28, 2024 @ 3:25 PM Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue... Source: Zacks Equity Research Feb 22, 2024 @ 10:15 PM BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings a... Source: Zacks Equity Research Jan 25, 2024 @ 2:26 PM Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY... Source: Kinjel Shah Jan 24, 2024 @ 3:42 PM Biotech Stock Roundup: GILD Down on Study Results,... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $116.43 $-2.8 $-5.03 Diluted EPS $115.37 $-2.8 $-4.47 Revenue $ .2M $ M $ .1M Gross Profit $ $ $ Net Income / Loss $ 1.72B $ -43.31M $ -47.87M Operating Income / Loss $ -300.52M $ -42.9M $ -49.93M Cost of Revenue $ $ $ Net Cash Flow $ -35.96M $ 63.92M $ -43.74M PE Ratio 0.00